Finance

Lists
Why is IMRX down ၂.၀၃%?
Dive Deeper
IMRX:NASDAQ
Immuneering Corp
၃.၃၈ US$
-၂.၀၃%
(-၀.၀၇၀) 1D
၃.၃၈ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
၃.၃၈ US$
High
၃.၅၄ US$
Low
၃.၂၉ US$
Mkt. cap
၂၁.၈၉ ကုဋေ
Avg. vol.
၇.၇၀ သိန်း
Volume
၁.၄၅ သန်း
52-wk high
၈.၄၈ US$
52-wk low
၃.၂၉ US$
EPS
-၁.၀၃ US$
Beta
၀.၄၉
Shares outstanding
၆.၄၈ ကုဋေ
No. of employees
၆၅
Open
၃.၃၈ US$
High
၃.၅၄ US$
Low
၃.၂၉ US$
Mkt. cap
၂၁.၈၉ ကုဋေ
Avg. vol.
၇.၇၀ သိန်း
Volume
၁.၄၅ သန်း
52-wk high
၈.၄၈ US$
52-wk low
၃.၂၉ US$
EPS
-၁.၀၃ US$
Beta
၀.၄၉
Shares outstanding
၆.၄၈ ကုဋေ
No. of employees
၆၅
News stories
From web sources and news partners
KPAX News
KPAX News
·
ပြီးခဲ့သည့် ၃၀ မိနစ်
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
FXStreet
FXStreet
·
ပြီးခဲ့သည့် ၃၇ မိနစ်
Dow Jones Industrial Average drops for a fifth day as AI rout widens
marketscreener.com
marketscreener.com
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
S&P 500, Dow Slide Into Correction Territory as Investors Seek Treasury Cover Amid Big-Tech Plunge
finance.biggo.com
finance.biggo.com
·
ပြီးခဲ့သည့် ၄၅ မိနစ်
Goldman Sachs: Year-End S&P 500 Rally Could Lose Half Its Punch as Fear Runs Hot
About Immuneering Corp
CEO-
Employees၆၅
Founded၂၀၀၈
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to IMRX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current ၃.၃၈ US$
၁၄.၀၀ US$ (+၃၁၄.၂၀%)
Average
၁၂.၅၀ US$ (+၂၆၉.၈၂%)
Lowest
၁၁.၀၀ US$ (+၂၂၅.၄၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
၁၄.၀၀ US$
+၃၁၄.၂%
11/18/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
၁၁.၀၀ US$
+၂၂၅.၄%
10/29/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
၁၂.၀၀ US$
+၂၅၅%
08/17/2026
Ami Fadia
Needham
Buy
Reiterated
၁၈.၀၀ US$
+၄၃၂.၅%
08/05/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
၁၇.၀၀ US$
+၄၀၃%
07/08/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
၂၀.၀၀ US$
+၄၉၁.၇%
05/19/2026
Jay Olson
Oppenheimer
Buy
Reiterated
၃၀.၀၀ US$
+၇၈၇.၆%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၉.၂၅ သန်း
၁.၀၆ ကုဋေ
၁.၄၀ ကုဋေ
၂.၀၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၄၉ သန်း
၄.၆၈ သန်း
၅.၀၀ သန်း
၅.၀၆ သန်း
Operating expense
၁.၃၈ ကုဋေ
၁.၅၃ ကုဋေ
၁.၉၀ ကုဋေ
၂.၅၈ ကုဋေ
Total operating expenses
၁.၃၈ ကုဋေ
၁.၅၃ ကုဋေ
၁.၉၀ ကုဋေ
၂.၅၈ ကုဋေ
Operating income
-၁.၃၈ ကုဋေ
-၁.၅၃ ကုဋေ
-၁.၉၀ ကုဋေ
-၂.၅၈ ကုဋေ
Other non operating income
၁.၅၆ သိန်း
၁.၀၉ သိန်း
၆.၄၇ သိန်း
၃.၉၁ သိန်း
EBT including unusual items
-၁.၁၆ ကုဋေ
-၁.၃၅ ကုဋေ
-၁.၇၃ ကုဋေ
-၂.၄၂ ကုဋေ
EBT excluding unusual items
-၁.၁၇ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၇၃ ကုဋေ
-၂.၄၂ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၁၆ ကုဋေ
-၁.၃၅ ကုဋေ
-၁.၇၃ ကုဋေ
-၂.၄၂ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၁၈
-၀.၂၁
-၀.၂၇
-၀.၃၇
Interest and investment income
၁.၈၆ သန်း
၁.၃၆ သန်း
၁.၀၈ သန်း
၁.၂၀ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၈၆ သန်း
၁.၃၆ သန်း
၁.၀၈ သန်း
၁.၂၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၃၇ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၈၉ ကုဋေ
-၂.၅၇ ကုဋေ
Gain or loss from assets sale
၂.၀၉ ထောင်
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ